Literature DB >> 11011997

Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [D-ala2, D-leu5]enkephalin from a cubic phase of glyceryl monooleate.

J Lee1, I W Kellaway.   

Abstract

The combined use of the lipophilic permeation enhancer, oleic acid together with polyethylene glycol 200 (PEG 200) as a co-enhancer and incorporated into the cubic liquid crystalline phase of glyceryl monooleate was investigated in the ex vivo buccal permeation of [D-Ala2, D-Leu5]enkephalin (DADLE) through porcine buccal mucosa mounted in a Franz cell. The addition of oleic acid (1%) and PEG 200 (1-10%) did not change the intact appearance of the cubic phase. PEG 200 increased the aqueous solubility of oleic acid incorporated into the cubic phase and hence promoted the transport of oleic acid into the porcine buccal mucosa. The solubilising effect of PEG 200 on oleic acid incorporated into the cubic phase was dependent on the PEG 200 concentration but was non-linear. The buccal permeation flux of DADLE significantly increased when 5% (P<0.01) or 10% (P<0.001) of PEG 200 was co-administered with 1% oleic acid compared with the cubic phase containing 1% oleic acid alone. The present results suggest that PEG 200 enhances the action of the lipophilic permeation enhancer oleic acid and that the combination of oleic acid and PEG 200 as a co-enhancer can be a useful tool to improve the membrane permeability in the buccal delivery of peptide drugs using a cubic liquid crystalline phase of glyceryl monooleate and water.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11011997     DOI: 10.1016/s0378-5173(00)00490-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.

Authors:  Luciana B Lopes; Denise A Ferreira; Daniel de Paula; M Tereza J Garcia; José A Thomazini; Márcia C A Fantini; M Vitória L B Bentley
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

Review 2.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

3.  Bioadhesive Drug Delivery System for Enhancing the Permeability of a BCS Class III Drug via Hot-Melt Extrusion Technology.

Authors:  Nicole S Mendonsa; Priyanka Thipsay; Dong Wuk Kim; Scott T Martin; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2017-02-28       Impact factor: 3.246

4.  Enhanced oromucosal delivery of progesterone via hexosomes.

Authors:  Nitin K Swarnakar; Vikas Jain; Vaibhav Dubey; Dinesh Mishra; N K Jain
Journal:  Pharm Res       Date:  2007-09-08       Impact factor: 4.200

5.  Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study.

Authors:  Munish Kumar Dhiman; Anupama Dhiman; Krutika K Sawant
Journal:  AAPS PharmSciTech       Date:  2009-03-12       Impact factor: 3.246

6.  Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation.

Authors:  Weijun Wu; Jing Li; Lin Wu; Baoyan Wang; Zhongyuan Wang; Qunwei Xu; Hongliang Xin
Journal:  AAPS PharmSciTech       Date:  2013-06-29       Impact factor: 3.246

7.  Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.

Authors:  Muhammad Rouf Akram; Mahmood Ahmad; Asad Abrar; Rai Muhammad Sarfraz; Asif Mahmood
Journal:  Drug Des Devel Ther       Date:  2018-02-21       Impact factor: 4.162

8.  New Insights on the Mechanism of Fatty Acids as Buccal Permeation Enhancers.

Authors:  Cristina Padula; Silvia Pescina; Sara Nicoli; Patrizia Santi
Journal:  Pharmaceutics       Date:  2018-10-24       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.